Company

CORXEL Pharmaceuticals

Biotechnology Research 300 Connell Dr 47 employees

Employees: 47
Contacts: 2
Emails: 2

www.corxelbio.com LinkedIn

CORXEL Pharmaceuticals Overview

Headquarters: 300 Connell Dr
Website: www.corxelbio.com
Industry: Biotechnology Research
Employees: 47
Founded: 2019
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biotech Cardiometabolic GLP-1 Stroke Hypertension

About CORXEL Pharmaceuticals

CORXEL is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for patients with cardiometabolic conditions around the world. Led by an experienced management team that has a strong track record of identifying, in-licensing and developing attractive clinical product candidates directed at validated targets with proven mechanisms of action (MoAs), CORXEL's diverse portfolio of clinical-stage product candidates has the potential to redefine treatment standards and address key limitations of current therapies for multiple cardiometabolic indications.

CORXEL Pharmaceuticals Contact Details

People in AeroLeads: 3
With contact data: 2
Email contacts: 2; 66.7% coverage

CORXEL Pharmaceuticals Org Chart

Sample employees and titles

Name	Title	Location	Contact
Niri (Tracy) Wu	Head of Cqa at Corxel		View
Jason Lam	Sr. Director of Clinical Operations	New York City Metropolitan Area, United States	Email
Chuan Wang	Jixing Pharmaceuticals - Director	Jing'an District, Shanghai, China	Email